Longitudinal study on the epidemiology and management of auto immune thrombocytopenia in Alger (AITP registry)

Study identification

• EU PAS number:
  EUPAS20416
• Study ID:
  20479
• Official title and acronym:
  Longitudinal study on the epidemiology and management of auto immune thrombocytopenia in Alger (AITP registry)
• DARWIN EU® study:
  No
• Study countries:
  American Samoa
• Study description:
  epidemiological, national, prospective, longitudinal study about the management of patients with auto-immune thrombocytopenia followed up by hematologists in the public sector in ALGERIA The mains objectives is assessing the incidence and prevalence of the ITP IN Algeria
• Study status:
  Planned

Research institutions and networks

Institutions

Clinica group CRO

Study timelines

Date when funding contract was signed

Planned:04/04/2017

Study start date

Planned:04/05/2017

Data analysis start date

Planned:04/05/2018

Date of final study report

Planned:04/11/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

AMGEN Algeria

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable